AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23729801
Drug: Ofatumumab 60
RxNorm normalized name: Ofatumumab
DrugBank: Ofatumumab (DB06650)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ofatumumab 60 mg
Trial: 23729801
Drug: Ofatumumab 100
RxNorm normalized name: ofatumumab 100 MG in 5 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofatumumab 100 mg
Trial: 19398651
Drug: PF‐00489791 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PF‐00489791 10 mg
Trial: 19398651
Drug: PF‐00489791 20/40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PF‐00489791 20/40 mg
Trial: 15885525
Drug: Integrated dual
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated dual disorders treatments
Trial: 10088066
Drug: Metoprolol (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (up to 200 mg/day)
Trial: 1836986
Drug: Cilazapril 2.5
RxNorm normalized name: cilazapril 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilazapril 2.5 mg/day
Trial: 2138051
Drug: Cilazapril (1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilazapril (1.25 mg/day and 5.0 mg/day)
Trial: 6772293
Drug: Adriamycin added
RxNorm normalized name: Adriamycin
DrugBank: Doxorubicin (DB00997)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adriamycin added to VAC chemotherapy
Trial: 17328806
Drug: Amodiaquine plus
RxNorm normalized name: Amodiaquine
DrugBank: Amodiaquine (DB00613)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amodiaquine plus placebo (10 mg/kg/day x 3 d)
Trial: 15465986
Drug: No active
RxNorm normalized name: Aveeno Active Naturals
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No active treatment (placebo)
Trial: 11145479
Drug: Antithrombin treatment
RxNorm normalized name: antithrombin III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antithrombin treatment (100 U/kg BW during 24 hours)
Trial: 9876448
Drug: Endolymphatic irradiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Endolymphatic irradiation with lipoiodine containing 131I (specific activity 4-6 mCu/ml)
Trial: 7989902
Drug: Atrial natriuretic
RxNorm normalized name: Atrial natriuretic factor
DrugBank: Atrial natriuretic peptide (DB15591)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atrial natriuretic peptide (ANP) infusion (10 ng kg‐1 min‐1) for 1 hour in EH
Trial: 7989902
Drug: Atrial natriuretic
RxNorm normalized name: Atrial natriuretic factor
DrugBank: Atrial natriuretic peptide (DB15591)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atrial natriuretic peptide (ANP) infusion during sodium nitroprusside (NP) infusion in EH
Trial: 9933789
Drug: Ultrasound contrast
RxNorm normalized name: ULTRASOUND CONTRAST MEDIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound contrast agents
Trial: 30560679
Drug: Melatonin (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (6 mg tablet)
Trial: 18025625
Drug: Alfentanil and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil and different doses of remifentanil
Trial: 3160273
Drug: Anticholinergic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticholinergic treatment with ipratropium bromide (Atrovent)
Trial: 26494833
Drug: Roxadustat with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roxadustat with oral iron
Trial: 24346757
Drug: Duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60 mg once daily for 11 days
Trial: 24160674
Drug: Text messaging
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Text messaging intervention to collect daily alcohol consumption data
Trial: 24160674
Drug: Text delivered
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Text delivered intervention on monthly alcohol expenditure
Trial: 18167173
Drug: cis-9, trans-11-conjugated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cis-9, trans-11-conjugated linoleic acid (CLA) 2 g/d for 12 weeks
Trial: 14624189
Drug: Olanzapine (10-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (10-20 mg/d)
Trial: 10982347
Drug: IFN induction
RxNorm normalized name: IFNγ
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN induction (daily) therapy
Trial: 10982347
Drug: IFN plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN plus ribavirin combination therapy
Trial: 1462021
Drug: Nebulized fenoterol
RxNorm normalized name: fenoterol
DrugBank: Fenoterol (DB01288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized fenoterol (5 mg)
Trial: 7809438
Drug: Nebulized salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulized salbutamol (5 mg)
Trial: 16236844
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide (0.5 mg)
Trial: 27746377
Drug: Intra-articular corticosteroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular corticosteroid injection followed by exercise therapy
Trial: 27746377
Drug: Intra-articular saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular saline injection followed by exercise therapy
Trial: 23837414
Drug: Combination (aromatherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination (aromatherapy and hand massage)
Trial: 17314262
Drug: Bar on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bar on 4 implants
Trial: 17314262
Drug: Bar on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bar on 2 implants
Trial: 17314262
Drug: Ball attachments
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ball attachments on 2 implants
Trial: 9886517
Drug: LNG rod
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LNG rod implants
Trial: 9886517
Drug: Norplant capsules
RxNorm normalized name: Norplant 3-oxime
DrugBank: Norelgestromin (DB06713)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norplant capsules
Trial: 8027856
Drug: Calcium plus
RxNorm normalized name: O Calcium Plus D
DrugBank: Cupric oxide (DB11134)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium plus trace minerals (1000 mg elemental Ca/d, 15.0 mg zinc/d, 5.0 mg manganese/d, 2.5 mg copper/d)
Trial: 8027856
Drug: Calcium only
RxNorm normalized name: Calcium only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium only (1000 mg elemental Ca/d)
Trial: 2755611
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of amniotic membrane
Trial: 28617537
Drug: Spirulina (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirulina (2 g daily for three months)
Trial: 17902008
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of sertraline (25 mg/day for 2 days, then 50 mg from day 3 to 90) and buspirone (5 mg three times a day for 7 days, then 10 mg from day 8 to 90) plus cognitive-behavioral treatment
Trial: 14659445
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of 200 mg disodium clodronate
Trial: 9135185
Drug: Rocuronium (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium (twice ED95 dose)
Trial: 3163212
Drug: High-dose Ara-C
RxNorm normalized name: cytarabine
DrugBank: Cytarabine (DB00987)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: High-dose Ara-C (HiDAC)
Trial: 3163212
Drug: Sequential asparaginase
RxNorm normalized name: Asparaginase
DrugBank: Asparaginase Erwinia chrysanthemi (DB08886)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sequential asparaginase
Trial: 30654929
Drug: Conservative CTO
RxNorm normalized name: Conserved dopamine neurotrophic factor
DrugBank: HER-902 (DB17948)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative CTO treatment (n=154)
Trial: 23649042
Drug: Doxycycline hyclate
RxNorm normalized name: Doxycycline Hyclate
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxycycline hyclate (20 mg, twice daily for 2 years)
Trial: 15950714
Drug: Deferred antiepileptic
RxNorm normalized name: ANTIEPILEPTICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferred antiepileptic drug treatment
Trial: 10216073
Drug: rhTPO and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhTPO and G‐CSF
Trial: 8682055
Drug: Spironolactone (12.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone (12.5, 25, 50, or 75 mg per day)
Trial: 2184556
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg atenolol (Tenormin)
Trial: 376390
Drug: Cimetidine 800
RxNorm normalized name: cimetidine 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 800 mg daily for 1 year maintenance therapy
Trial: 17061961
Drug: Zolpidem-MR 6.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem-MR 6.25 mg
Trial: 16702893
Drug: Zolpidem-MR 12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem-MR 12.5 mg
Trial: 11848519
Drug: Concurrent cisplatin-based
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent cisplatin-based chemotherapy and irradiation
Trial: 8342825
Drug: 5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/kg of 2.5% thiopental
Trial: 8342825
Drug: 0.7 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.7 g/kg alcohol
Trial: 31538887
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of mitiglinide and voglibose
Trial: 23221670
Drug: Device-assisted ultrasound-guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Device-assisted ultrasound-guided injection
Trial: 18062845
Drug: OROS hydromorphone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OROS hydromorphone 16 mg with 0% alcohol
Trial: 18062845
Drug: OROS hydromorphone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OROS hydromorphone 16 mg with 4% alcohol
Trial: 18062845
Drug: OROS hydromorphone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OROS hydromorphone 16 mg with 20% alcohol
Trial: 18062845
Drug: OROS hydromorphone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OROS hydromorphone 16 mg with 40% alcohol
Trial: 12366728
Drug: Topiramate 50
RxNorm normalized name: topiramate 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate 50 mg
Trial: 16432681
Drug: Topiramate (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (both doses)
Trial: 3147046
Drug: Nalmefene (opioid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalmefene (opioid antagonist)
Trial: 27609188
Drug: Tidal volume
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tidal volume of 6 ml/kg
Trial: 27609188
Drug: Tidal volume
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tidal volume of 10 ml/kg
Trial: 23994882
Drug: Isosorbide mononitrate
RxNorm normalized name: Isosorbide Mononitrate
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide mononitrate (ISMN) 20 mg retarded release orally twice per day, n=30
Trial: 11694921
Drug: Group 2:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 2: Resection of any inferior clavicle spur, violation of the inferior joint capsule, and removal of articular cartilage to a level adjacent with the resected acromion
Trial: 9400772
Drug: Topical 0.1%
RxNorm normalized name: adapalene topical 0.1% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 0.1% dexamethasone (DMS)
Trial: 26520171
Drug: Topical 0.1%
RxNorm normalized name: adapalene topical 0.1% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 0.1% fluorometholone (FML)
Trial: 24271093
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy (CPT) for airway clearance
Trial: 18441854
Drug: BPO 5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BPO 5% monotherapy
Trial: 18441854
Drug: BPO 10%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BPO 10% monotherapy
Trial: 10165114
Drug: Standard actuator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard actuator with inhaled beclomethasone dipropionate (0.5 mg twice daily)
Trial: 24943285
Drug: HAD (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HAD (20 g beef per day)
Trial: 24943285
Drug: BOLD diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BOLD diet (113 g beef per day)
Trial: 24943285
Drug: DASH diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DASH diet (28 g beef per day)
Trial: 20629812
Drug: Any medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Any medication change or therapeutic lifestyle changes counseling
Trial: 12020302
Drug: CEEs, 0.45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEEs, 0.45 mg/d and MPA, 2.5 mg/d
Trial: 12020302
Drug: CEEs, 0.45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEEs, 0.45 mg/d and MPA, 1.5 mg/d
Trial: 12020302
Drug: CEEs, 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEEs, 0.3 mg/d and MPA, 1.5 mg/d
Trial: 23326930
Drug: Test treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test treatment
Trial: 7712301
Drug: Omeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (20 mg daily for 4 weeks) + Amoxycillin (1 g three times daily for 2 weeks) + Metronidazole (1 g daily for 2 weeks)
Trial: 7712301
Drug: Omeprazole +
RxNorm normalized name: Omeprazole + SyrSpend SF Alka
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole + Antibiotics
Trial: 238790
Drug: Clemastine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clemastine (1 mg b.d.)
Trial: 238790
Drug: Chlorpheniramine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpheniramine (4 mg b.d.)
Trial: 18227366
Drug: Bupropion hydrochloride
RxNorm normalized name: Bupropion Hydrochloride
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion hydrochloride therapy with smoking counseling
Trial: 7870745
Drug: Mianserin (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mianserin (60 mg/day in three oral doses)
Trial: 7870745
Drug: Amitriptyline (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (75 mg/day in three oral doses)
Trial: 1958436
Drug: Standard nicardipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard nicardipine (STD) 30 mg three times daily for 28 days
Trial: 1958436
Drug: Sustained release
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained release nicardipine (SR) 60 mg twice daily for 28 days
Trial: 616212
Drug: CO inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CO inhalation (1100 ppm CO-air mixture)
Trial: 27591965
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of disclaimer label and pre-exposure message
Trial: 26338956
Drug: Ivabradine at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivabradine at 7.5 mg twice daily
Trial: 18550399
Drug: M6G (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M6G (10 mg/70 kg and 20 mg/70 kg)
Trial: 17803344
Drug: Ulinastatin therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ulinastatin therapy (30,000 U/kg/day for 3 days)
Trial: 17803344
Drug: IVIG therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIG therapy (1 g/kg/dose)
Trial: 14729733
Drug: Linezolid 600
RxNorm normalized name: linezolid 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linezolid 600 mg orally every 12 h for a total of six doses
Trial: 17019296
Drug: High NaHCO3
RxNorm normalized name: HIGH DENSITY POLYETHYLENE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High NaHCO3 intake (0.5 g x kg(‐1) x d(‐1))
Trial: 8959154
Drug: Intravenous bacille
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous bacille Calmette‐Guérin (BCG) vaccination
Trial: 3911963
Drug: suprofen syrup
RxNorm normalized name: Suprofen
DrugBank: Suprofen (DB00870)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: suprofen syrup
Trial: 3911963
Drug: paracetamol syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: paracetamol syrup
Trial: 26644241
Drug: Eplerenone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone (50 mg, oral)
Trial: 24041860
Drug: Tramadol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (2 mg/kg-2 ml)
Trial: 24041860
Drug: Ketamine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.5 mg/kg-2 ml)
Trial: 24041860
Drug: Control (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (2 ml serum physiologic)
Trial: 12576897
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin injection (20 to 30 U, approximately 0.3 U/kg)
Trial: 10494574
Drug: Hydrocortisone 20
RxNorm normalized name: hydrocortisone 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone 20 mg administered twice daily for 10 days
Trial: 7356891
Drug: 160 mg
RxNorm normalized name: nadolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg propranolol
Trial: 11422094
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg metoprolol
Trial: 22958078
Drug: Tadalafil 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 5.0 mg
Trial: 18286351
Drug: Low-dose steroid
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose steroid therapy (prednisolone 0.4 mg/kgBW/day, tapered to 5-10 mg/day over 24 months)
Trial: 18286351
Drug: Low-dose steroid
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose steroid therapy (prednisolone)
Trial: 18286351
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (dipyridamole or zilazep hydrochloride 150 or 300 mg/day)
Trial: 9858113
Drug: Dexamethasone (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (3 mg/day)
Trial: 14529881
Drug: Reduced CsA
RxNorm normalized name: CsA
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduced CsA dose (5 mg/kg/d) and daclizumab (group A, n = 16)
Trial: 14529881
Drug: Normal CsA
RxNorm normalized name: CsA
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal CsA dose (10 mg/kg/day) without daclizumab (group B, n = 16)
Trial: 14529881
Drug: Reduced CsA
RxNorm normalized name: CsA
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduced CsA dose (5 mg/kg/d) and daclizumab (group A)
Trial: 14529881
Drug: Normal CsA
RxNorm normalized name: CsA
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal CsA dose (10 mg/kg/day) without daclizumab (group B)
Trial: 11113421
Drug: sublingual estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: sublingual estradiol 17beta
Trial: 1532534
Drug: Cilazapril 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilazapril 5.0 mg/day + Hydrochlorothiazide 12.5 mg/day
Trial: 3921597
Drug: 0.02 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.02 mg/kg NAL infusion
Trial: 3921597
Drug: 0.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg NAL infusion
Trial: 3921597
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg NAL infusion
Trial: 3921597
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of NAL
Trial: 3921597
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of NAL
Trial: 27687342
Drug: Multisource feedback
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multisource feedback with monthly coaching meetings
Trial: 27687342
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no monthly coaching meetings)
Trial: 18796350
Drug: Magnesium sulphate
RxNorm normalized name: Magnesium sulphate
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium sulphate (5 g) before each chemotherapy course and magnesium subcarbonate (500 mg) three times per day orally during treatment intervals
Trial: 15812765
Drug: Prophylactic brimonidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic brimonidine in patients on anticoagulant or antiplatelet treatment
Trial: 10524634
Drug: UDCA 600
RxNorm normalized name: UDCA
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UDCA 600 mg/day